CY1117187T1 - Συνθεσεις οι οποιες περιλαμβανουν saccharomyces boulardii και υπεροξειδικη δισμουταση για τον ελεγχο της παχυσαρκιας - Google Patents

Συνθεσεις οι οποιες περιλαμβανουν saccharomyces boulardii και υπεροξειδικη δισμουταση για τον ελεγχο της παχυσαρκιας

Info

Publication number
CY1117187T1
CY1117187T1 CY20161100122T CY161100122T CY1117187T1 CY 1117187 T1 CY1117187 T1 CY 1117187T1 CY 20161100122 T CY20161100122 T CY 20161100122T CY 161100122 T CY161100122 T CY 161100122T CY 1117187 T1 CY1117187 T1 CY 1117187T1
Authority
CY
Cyprus
Prior art keywords
compositions
saccharomyces boulardii
include saccharomyces
obesity control
peroxide bonding
Prior art date
Application number
CY20161100122T
Other languages
English (en)
Inventor
Ignazio Castagliuolo
Paola Brun
Immacolata Busiello
Niccolò MIRAGLIA
Original Assignee
Gnosis S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis S.P.A. filed Critical Gnosis S.P.A.
Publication of CY1117187T1 publication Critical patent/CY1117187T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Αποκαλύπτεται μία σύνθεση η οποία περιέχει Saccharomyces cerevisiae var boulardii και το ένζυμο υπεροξειδική δισμουτάση.
CY20161100122T 2011-08-03 2016-02-15 Συνθεσεις οι οποιες περιλαμβανουν saccharomyces boulardii και υπεροξειδικη δισμουταση για τον ελεγχο της παχυσαρκιας CY1117187T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001488A ITMI20111488A1 (it) 2011-08-03 2011-08-03 Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
EP12750344.9A EP2739295B1 (en) 2011-08-03 2012-08-02 Formulations comprising saccharomyces boulardii and superoxide dismutase for controlling obesity

Publications (1)

Publication Number Publication Date
CY1117187T1 true CY1117187T1 (el) 2017-04-05

Family

ID=44675697

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100122T CY1117187T1 (el) 2011-08-03 2016-02-15 Συνθεσεις οι οποιες περιλαμβανουν saccharomyces boulardii και υπεροξειδικη δισμουταση για τον ελεγχο της παχυσαρκιας

Country Status (25)

Country Link
US (1) US9555082B2 (el)
EP (1) EP2739295B1 (el)
JP (1) JP6126595B2 (el)
KR (1) KR101954674B1 (el)
CN (1) CN103764156A (el)
AU (1) AU2012292029B2 (el)
BR (1) BR112014001336A2 (el)
CA (1) CA2843794C (el)
CY (1) CY1117187T1 (el)
DK (1) DK2739295T3 (el)
ES (1) ES2562647T3 (el)
GE (1) GEP20166436B (el)
HR (1) HRP20160293T1 (el)
HU (1) HUE027121T2 (el)
IL (1) IL230723B (el)
IT (1) ITMI20111488A1 (el)
MX (1) MX349242B (el)
PL (1) PL2739295T3 (el)
RS (1) RS54594B1 (el)
RU (1) RU2600843C2 (el)
SI (1) SI2739295T1 (el)
SM (1) SMT201600086B (el)
UA (1) UA112990C2 (el)
WO (1) WO2013017650A2 (el)
ZA (1) ZA201400758B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2870969A1 (fr) * 2013-11-08 2015-05-13 Biocodex Composition pharmaceutique pour la réduction de la masse adipeuse
KR101893735B1 (ko) * 2018-05-04 2018-08-31 주식회사이-글벳 열 안정성이 강화된 효모를 이용한 정장효능이 있는 산제 동물용 의약품 조성물 및 그 제조 방법
TW202408555A (zh) * 2022-06-29 2024-03-01 香港商香港微生物菌群創新中心有限公司 使用微生物治療肥胖症的方法和組合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
SE529185C2 (sv) 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
CN101172118A (zh) 2006-07-26 2008-05-07 美国医迈科技有限公司 作为抗传染病替代药物的益生微生物
KR20080094459A (ko) * 2007-04-20 2008-10-23 주식회사 엘지생활건강 항산화 활성을 갖는 화장료 조성물
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
CN101130068B (zh) * 2007-09-04 2010-05-19 陈坤鑫 Sod减肥酒及其生产方法
US8476058B2 (en) * 2007-12-26 2013-07-02 Lesaffre Et Compagnie Probiotic yeast compositions and methods for inflammatory diseases
WO2009102152A2 (ko) * 2008-02-14 2009-08-20 Mealtobalance Co., Ltd. 천연물을 이용한 발효물의 제조 방법 및 상기 방법에 의해 제조된 발효물을 포함하는 식품 또는 의약품
JP5677086B2 (ja) * 2008-06-02 2015-02-25 株式会社カネカ 固体脂を使ったマイクロカプセルの製造方法
JP2010100530A (ja) * 2008-10-21 2010-05-06 Ikeda Shokken Kk 抗肥満剤
WO2010083227A1 (en) * 2009-01-14 2010-07-22 Nutrafood Nutrients, Inc. Consumable dissolving film comprising active ingredients derived from bacteria and fungi
EP2216036A1 (en) 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
CN102458415B (zh) 2009-06-19 2015-05-20 杜邦营养生物科学有限公司 治疗糖尿病及相关病症的双歧杆菌
JP2011004640A (ja) * 2009-06-24 2011-01-13 Kaneka Corp 魚介エキスの精製方法
EP2459202A1 (en) * 2009-07-31 2012-06-06 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
IT1396074B1 (it) * 2009-10-12 2012-11-09 Axioma S R L Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'

Also Published As

Publication number Publication date
JP6126595B2 (ja) 2017-05-10
US20140205581A1 (en) 2014-07-24
EP2739295A2 (en) 2014-06-11
US9555082B2 (en) 2017-01-31
RU2014103483A (ru) 2015-08-10
HRP20160293T1 (hr) 2016-04-22
WO2013017650A3 (en) 2013-04-04
JP2014521343A (ja) 2014-08-28
AU2012292029B2 (en) 2017-03-09
UA112990C2 (uk) 2016-11-25
HUE027121T2 (en) 2016-08-29
KR101954674B1 (ko) 2019-03-06
SI2739295T1 (sl) 2016-04-29
GEP20166436B (en) 2016-02-25
PL2739295T3 (pl) 2016-06-30
CA2843794A1 (en) 2013-02-07
WO2013017650A2 (en) 2013-02-07
RS54594B1 (en) 2016-08-31
AU2012292029A1 (en) 2014-02-20
SMT201600086B (it) 2016-04-29
ZA201400758B (en) 2015-10-28
CN103764156A (zh) 2014-04-30
IL230723B (en) 2018-01-31
RU2600843C2 (ru) 2016-10-27
MX349242B (es) 2017-07-18
CA2843794C (en) 2021-11-09
KR20140051279A (ko) 2014-04-30
DK2739295T3 (en) 2016-03-14
ITMI20111488A1 (it) 2013-02-04
BR112014001336A2 (pt) 2017-07-04
IL230723A0 (en) 2014-03-31
NZ620579A (en) 2015-11-27
EP2739295B1 (en) 2015-12-30
ES2562647T3 (es) 2016-03-07
MX2014001327A (es) 2014-02-27

Similar Documents

Publication Publication Date Title
CO6561839A2 (es) Alteracion genómica dirigida
CY1121560T1 (el) Ανοσογονικη συνθεση
AU2015317711B2 (en) Compositions comprising recombinant Bacillus cells and another biological control agent
TR201910320T4 (tr) Karaciğer organoidi, kullanımları ve elde edilmesine yönelik kültür yöntemi.
MA39819A (fr) Méthodes et compositions d'immunomodulation
PH12014501286A1 (en) Oral care whitening compositions
MX2015000087A (es) Uso de una composicion adhesiva para proporcionar una union en un entorno humedo.
CO6630182A2 (es) Microorganismos y métodos para la biosíntesis de butadieno
BR112012000777A2 (pt) embalagem de bateria.
MA34521B1 (fr) Polypeptides de relaxine modifiés et leurs utilisations
IN2015DN03055A (el)
MY169141A (en) Biodegradable compositions, methods and uses thereof
ECSP12012105A (es) Antídotos de Anticoagulantes
BR112016016524A2 (pt) célula de levedura transformada
CR20130533A (es) INHIBIDORES POTENTES Y SELECTIVOS DE NAv1.3 y NAv1.7
BR112016003256A2 (pt) micro-organismos modificados para usar fontes não convencionais de fósforo ou enxofre
EA201290623A1 (ru) Лактобациллы с антиоксидантным действием
WO2013123046A3 (en) Cathode buffer materials and related devices and methods
CY1117187T1 (el) Συνθεσεις οι οποιες περιλαμβανουν saccharomyces boulardii και υπεροξειδικη δισμουταση για τον ελεγχο της παχυσαρκιας
EA201300733A1 (ru) Рекомбинантные микобактерии в качестве вакцины
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
MX2022000516A (es) Metodos relacionados con celulas pluripotentes.
TR201008916A2 (tr) Zararlı organizma kontrol kompozisyonu ve zararlı organizmaların kontrol yöntemi
BR112013005570A2 (pt) tampa para um recipiente